Citation: Framroze B., Havaldar F., Misal S. An in-vitro study on the regulation of oxidative protective genes in human gingival and intestinal epithelial cells after treatment with salmon protein hydrolysate peptides. Functional Foods in Health and Disease 2018; 8(8):398-411. https://doi.org/10.31989/ffhd.v8i8.529 ABSTRACT Background: Under physiological conditions, molecular oxygen generates reactive oxygen species (ROS) as metabolic by-products. In the absence of an adequate defense mechanism, the accumulation of ROS leads to cell membrane and DNA damage, in addition to tissue degeneration. The up/down regulation of one or more oxidative stress-related genes is one mechanism which confers cytoprotection to tissues exposed to oxidative injury.
donors [15] . Invitro gene expression has also been studied in human corneal endothelial cells (HCECs) to see if nuclear oxidative DNA damage increases with age and whether HCECs respond to this damage by upregulating their expression of oxidative stress and DNA damage-signaling genes in an age-dependent manner [16] . Four of 84 genes demonstrated a statistically significant age-related difference in the expression of oxidative stress-related genes.
Studies have shown that diet can also play a role in the regulation of oxidative protective genes. A recent study aiming to identify molecular markers of diet-related diseases in response to food evaluated peripheral blood mononuclear cells (PBMC) as a model in-vitro system as a readily available source of RNA to discern gene expression signatures in relation to personalized obesity treatment. PBMC were collected from obese men before and after an 8-week low-calorie diet (LCD) to lose weight. Changes in gene expression before and after the LCD were validated by qRT-PCR and demonstrated a decrease in some specific oxidative stress and inflammation genes, such as apolipoprotein 1 (APOL1) and NF-kB repression factor (NFKB) [17] .
The objective of this study is to measure the up/down regulation of 84 oxidative protective NRF2 genes within primary human gingival epithelial cells (HGEPp) and human intestinal epithelial cells (HIEC-6) when treated with varying concentrations of salmon protein hydrolysate (SPH) solution. These two cells lines were selected as in-vitro representatives of the GI tract similar to the bronchial epithelial cells used by Pierrou et al in COPD. As the major site of first entry for xenobiotics, the oral cavity and gastrointestinal tract are continuously exposed to a broad array of compounds with ROS capability. Further mucosal metabolism can lead to metabolites with increased toxicity, increasing the susceptibility of the oral cavity and gastrointestinal tract to oxidative metabolites, chemical toxicity, and potential necrotizing colitis. SPH contains a multitude of bioactive peptides. The results of this study will be used to guide the development of a functional food which confers a protective effect on the gastrointestinal tract, which can be used in conjunction with medical treatment in the control of Inflammatory Bowel Disease (IBD), such as ulcerative colitis and Crohn's disease.
METHODS AND MATERIALS

Chemicals and Reagents
Salmon Protein Hydrolysate Powder was procured from Hofseth Biocare AS, Norway as a light yellow free flowing powder supplied as Batch No. 17-006. HGEPp cells were purchased from Cell-n-Tec Advanced Cell Systems AG and HIEC-6 cells were purchased from the ATCC, USA. The RNEasy Plus Micro Kit, RNase-free DNase Set, RT 2 Easy First Strand Kit (DNA generator) and RT 2 SYBR ® Green fluor qPCR master-mix were purchased from Qiagen N.V., USA.
Oxidative Stress RT 2 profiler PCR arrays (84 protective genes) were purchased from Qiagen N.V.,
USA. The iCycler PCR system from Bio-Rad Inc., USA was used for the RT-PCR.
Cell Cultures
Pooled primary HGEPp cells were propagated in CnT-Prime epithelial culture medium provided by Cell-n-Tec on 100 mm petri dishes coated with 30 mg/ml Type I rat tail collagen (BD Biosciences) diluted in Dulbecco's phosphate-buffered saline in a 1:5 ratio (DPBS). This cell type was chosen since SPH has been studied as an oral solution formulation in patients, which puts this Further dilutions were prepared in DMSO from the 100 mM DMSO stock and the DMSO dilution was then added into 10 mL of Dulbecco's phosphate-buffered saline to arrive at final concentrations of 25, 50, and 100 µM/ml of SPH.
All dosing solutions contained 0.3% of DMSO which is below the maximum tolerated DMSO concentration of 0.8% for HGEPp and HIEC-6 cells.
Pre-Treatment of HGEPp & HIEC-6 cells with SPH solutions and DMSO blank
Dish cell concentrations were selected to be 2.5×10 5 /ml to yield an OD absorbance within the linear portion of the control curve for both cells lines. Once the cells were cultured and ready on the dishes, the media was removed and discarded. The cells were washed gently with DPBS 2-3 times and the last wash removed and discarded. Six HGEPp and HIEC-6 cell culture dishes were then pretreated for 24 h with SPH at 25, 50, and 100 g/mL concentrations (in duplicate) at 37°C. One cell culture dish for each cell line was pretreated for 24 h with the DMSO blank solution at 37°C.
mRNA preparation from cells
The RNeasy UCP Micro Kit was used to purify mRNA from both HGEPp and HIEC-6 treated cells. After discarding and washing treatments, the cells were pelleted by centrifugation for 5 min at 1000 RPM in a centrifuge tube. All the supernatant was carefully removed by aspiration, making sure all the cell medium has been removed thoroughly. The cells were disrupted by adding 350 µl buffer RULT in order to loosen the cell pellet from the tube and then vortexed to mix thoroughly. Next, the mixture was homogenized by being passed through the lysate 5 times through 20-gauge needle fitted to an RNase-free syringe. 350 µl of 70% ethanol was added to the lysate and mixed again by pipetting. Then the sample was transferred, including any precipitate that may have formed, to an RNeasy UCP MinElute spin column placed in a 2 ml collection tube and centrifuged for 15 s at 10,000 rpm. The flow thru was discarded. 350 µl Buffer RUWT was added to the spin column and centrifuged for 15 s at 10,000 rpm to wash the membrane. The flow thru was discarded. 10 µl DNase I stock solution was added to 70 µl Buffered RDD. After being mixed gently, 80ul of the DNase I mix was added directly to the spin-column membrane and vortexed for 15 min. 350 µl Buffer RUWT was added to the spin column and centrifuged for 15 s at 10,000 rpm to wash it and the flow thru was discarded. The spin column was placed in a new 2 ml collection tube. 500 µl Buffer RUPE was added and centrifuged for 15 s at 10,000 rpm. The flow thru was discarded. The spin column was washed again with 500 µl of 80% ethanol and placed in a new 2 ml collection tube and centrifuge for 5 min at full speed with the lid open to make sure all ethanol is removed. The spin column was placed in a new 1.5 ml collection tube, 14 µl ultra-clean water was added directly to the center of the spin-column membrane, and the lid was closed and centrifuged for 1 min at full speed to elute the RNA. The dead volume of the spin column is 4 µl. Eluted with 16 µl ultra-clean water to yield a 20 µl (4 µg) RNA eluate.
cDNA prep for RT-PCR
A RNA sample from each of the above seven treatments was added to 40 µl of Buffer GE2 (gDNA elimination buffer) and RNase-free H2O to make a final volume of 60 µl. The sample was incubated at 37°C for 5 min and immediately placed on ice for 2 minutes. 62 µl of the BC5 Reverse Transcriptase Mix was added to each 60 µl RNA sample for a final volume of 102 µl. The sample was then incubated at 42°C for exactly 15 minutes and then the reaction was immediately stopped through being heating at 95°C for 5 minutes. Sample was then ready for PCR.
Human Oxidative Stress RT 2 Profiler PCR Array
RT-PCR is a highly sensitive and reliable method for gene expression analysis.
The assay was used to analyze expression levels of 84 genes related to oxidative stress in HIEC-6 cells pre-treated with SPH at 25, 50, and 100 g/ml for 24 h. The cDNA from above was mixed with the RT 2 SYBR
Green fluor Mastermix and aliquoted into the wells of the RT 2 Profiler PCR Array shown below.
RT-PCR was performed on an iCycler. Gene expression was compared using Ct values and the results were calculated using ΔΔ Ct method with normalization to the average expression levels of the five common genes (ACTB, B2M, GAPDH, HPRT, and RPL13A) The selection of the 96 well array of test genes and housekeeping genes are shown below.
ANTIOXIDANTS
Glutathione peroxidases (GPx): GPX1, GPX2, GPX3, GPX4, GPX5, GPX6, GPX7, GSTP1, GSTZ1. Peroxiredoxins (TPx): PRDX1, PRDX2, PRDX3, PRDX4, PRDX5, PRDX6. The genomic DNA control (GDC) specifically detects non-transcribed genomic DNA contamination with a high level of sensitivity. The reverse-transcription control (RTC) tests the efficiency of the reverse-transcription reaction performed with the RT 2 First Strand Kit by detecting template synthesized from the kit's built-in external RNA control. The positive PCR control (PPC) consists of a pre-dispensed artificial DNA sequence and the assay that detects it so that the efficiency of the polymerase chain reaction is quantified and the controls are in replicates to ensure intra-plate consistency.
RESULTS
Upregulated oxidative stress genes
Treatment of HGEPp cells with SPH demonstrated up-regulation with a Fold Change greater than two for sixteen human oxidative stress-related genes-APOE, CYGB, EPX, FTH1, GCLC, GPX1, GSR, GSTZ1, HMOX1, MBL2, MSRA, NOS2, NQO1, PRDX5, SELS, SOD1. In contrast, treatment of HIEC-6 cells with SPH demonstrated up-regulation with a Fold Change greater than two for eleven human oxidative stress-related genes -APOE, EPX, FTH1, GCLC, GSS, HMOX1, MBL2, NOS2, NQO1, PRDX5, SOD1 at the 100 µM/ml SPH concentration (Table 1 & 2) . The DMSO blank treatments did not show any change in regulation for any gene in the array. Ten genes showed common upregulation in both cell lines -APOE, EPX, FTH1, GCLC, HMOX1, MBL2, NOS2, NQO1, PRDX5, SOD1. (Tables 3 & 4) . Seven common genes revealed downregulation in both cell lines -ALOX12, MGST3, MPO, NCF1, NOX5, PTGS2, SRXN1. Dose dependent response genes Additionally, two upregulated genes, FTH1 and HMOX1 in HGEPp cells and three upregulated genes, APOE, FTH1 and HMOX1 in HIEC-6 cells showed a dose-dependent result at the two lower doses of 25 and 50 µM/ml of SPH treatment. The ALOX12 gene showed a dose dependent downregulation in both HGEP and HIEC-6 cells (Table 5 ). None of the other genes showed a greater than two-fold change in upregulation nor a less than 50% change in down-regulation, when the SPH concentration was reduced to 50 and 25 µM/ml. [20] . Food intake has specifically been shown to modulate gene expression, particularly within the GI tract. Ismail et al have described the effect of germinated brown rice on the expression of the peroxisome proliferator-activated receptor gamma gene [21] . Down regulation of the PPARγ gene likely contributes to germinated brown rice's antiobesity effects.
FTH1 and HMOX1 gene upregulation
Iron is required for normal cell growth and proliferation. However, excess iron is potentially harmful, as it can catalyze the formation of toxic reactive oxygen species (ROS). Thus, cells have evolved highly regulated mechanisms for controlling intracellular iron levels. Chief among these is the sequestration of iron. The FTH1 gene encodes the heavy subunit of ferritin, the major intracellular iron storage protein in humans, which sequesters free iron in a soluble and nontoxic state from dietary sources of iron. Previous studies have shown that increased synthesis of both subunits of ferritin occurs when exposed to oxidative stress [22] . Ferritin H or L overexpression reduced the accumulation of ROS in response to an oxidant challenge.
Our results demonstrate that up regulation of FTH1 do not solely need to be in response to an oxidant challenge and may be induced by specific activator peptides formed upon digestion of consumed food. SPH has been shown to increase circulatory ferritin levels in situationally anemic women [23] . This gene assay result indicates a possible mechanism for the observed increase in serum ferritin as being a direct up-regulation of the FTH1 gene producing more ferritin and thereby increasing overall iron in the serum.
HMOX1 gene expression is similarly induced by oxidative stress and seems to confer cytoprotection. The resultant HO1 enzyme catalyzes the degradation of heme, which produces biliverdin, ferrous iron, and carbon monoxide. It cleaves the heme ring at the alpha-methene bridge to form biliverdin, which is converted to bilirubin by biliverdin reductase. The carbon monoxide released from heme oxygenase reactions has also been shown to influence vascular tone and the function of nitric oxide synthase [24] .
Several studies have also indicated that the ability to upregulate HO-1 expression is an important protective factor in many diseases such as cardiovascular disease, renal transplantation, and necrotizing enterocolitis [25] . Our research is focused on following-up with one specific clinical application-enteral SPH powder in the treatment of the neonatal intestinal inflammatory disease and necrotizing enterocolitis (NEC). HO-1 deficiency has been shown to lead to increased NEC development, while HO-1 induction increased Treg/Teff ratios and prevented NEC development in animal models [26] .
ALOX12 gene down regulation
Metabolic syndrome is a term used when the clustering of at least three of five of the following medical conditions occurs: abdominal (central) obesity, elevated blood pressure, elevated fasting plasma glucose (or overt diabetes), high serum triglycerides, and low high-density lipoprotein (HDL) levels.
ALOX12, a lipoxygenase-type enzyme, is encoded by the ALOX12 gene and is characterized by its ability to metabolize AA into 15(S)-HETE, a hormone-like autocrine and paracrine signaling agent, involved in the inflammation response and metabolic syndrome. Elevated ALOX12 levels have been implicated in type 1 diabetes, in the fat cells of white adipose tissue of obese diabetic patients and in excessive production of reactive oxygen species and inflammation [27] . As a result, down-regulation of ALOX12 and its metabolite(s) by SPH may contribute to the retardation of obesity, diabetes, hypertension, and/or metabolic syndrome.
CONCLUSIONS
It may be concluded from our results that salmon protein hydrolysate powder contains bioactive peptides that can up/down regulate certain oxidative protective genes in human epithelial cells. The unusually high number of genes shown to be impacted may be a direct result of the over 250 peptides of molecular weights between 1500 to 20,000 Dalton that are present in the test article, that could act as gene modulators. The upregulation in the HMOX1 gene, particularly in intestinal epithelial cells, could be the first step to developing a food based anti-inflammatory powder to help stabilize GI tissue damage via up-regulation of the HO-1 specific anti-oxidative enzyme in the GI tract. A follow-up study with enteral SPH treatment in the NEC animal model is under consideration. 
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